MiR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12

Biomedicine and Pharmacotherapy

Volumn 74, Issue , 2015, Pages 215-221

  Zhang, Jian ^a   Liu, Jing ^a   Liu, Yong ^a   Wu, Weibin ^a   Li, Xiaojun ^a   Wu, Yonghui ^a   Chen, Huiguo ^a   Zhang, Kai ^a   Gu, Lijia ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

CAFs; CXCL12; Lung cancer; MiR 101

Indexed keywords

MICRORNA; MICRORNA 101; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; MIRN101 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG CANCER; METASTASIS INHIBITION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA ANALYSIS; TUMOR INVASION; TUMOR SPHEROID; CELL MOTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; DISEASE PROGRESSION; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84940884425     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.08.013     Document Type: Article

References (28)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011, 61:212-236.
3. Goubran H.A., Kotb R.R., Stakiw J., Emara M.E., Burnouf T. Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 2014, 7:9-18.
4. Dittmer J., Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin. Cancer Biol. 2014.
5. Coleman S.J., Bruce C., Chioni A.M., Kocher H.M., Grose R.P. The ins and outs of fibroblast growth factor receptor signalling. Clin. Sci. (London) 2014, 127(4):217-231.
6. Krstic J., Santibanez J.F. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal 2014, 2014:521754.
7. Wilson J.S., Pirola R.C., Apte M.V. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression. Front Physiol. 2014, 5:52.
8. Wood S.L., Pernemalm M., Crosbie P.A., Whetton A.D. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat Rev. 2014, 40(4):558-566.
9. Fang H., Declerck Y.A. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013, 73(16):4965-4977. Aug 15.
10. Dalmay T. MicroRNAs and cancer. J. Intern. Med. 2008, 263:366-375.
11. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
12. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
13. Konno Y., Dong P., Xiong Y., Suzuki F., Lu J., Cai M., Watari H., Mitamura T., Hosaka M., Hanley S.J., Kudo M., Sakuragi N. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 2014, 5(15):6049-6062.
14. Wang L., Zhang L.F., Wu J., Xu S.J., Xu Y.Y., Li D., Lou J.T., Liu M.F. IL-1β-mediated repression of microRNA-101 Is crucial for inflammation-promoted lung tumorigenesis. Cancer Res. 2014, 74(17):4720-4730.
15. Hu Z., Lin Y., Chen H., Mao Y., Wu J., Zhu Y., Xu X., Xu X., Li S., Zheng X., Xie L. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem. Biophys. Res. Commun. 2013, 435(1):82-87.
16. Xu Y., An Y., Wang Y., Zhang C., Zhang H., Huang C., Jiang H., Wang X., Li X. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol. Rep. 2013, 29(5):2019-2024.
17. Yin J., Wang M., Jin C., Qi Q. miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis. Oncol. Lett. 2014, 7(2):461-465.
18. Wang L., Zhang L.F., Wu J., Xu S.J., Xu Y.Y., Li D., Lou J.T., Liu M.F. IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. Cancer Res. 2014, (June (23)).
19. Roybal J.D., Zang Y., Ahn Y.H., Yang Y., Gibbons D.L., Baird B.N., Alvarez C., Thilaganathan N., Liu D.D., Saintigny P., Heymach J.V., Creighton C.J., Kurie J.M. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol. Cancer Res. 2011, 9(1):25-35.
20. Della V., ittoria S., carpati G., Calura E., Di M., arino M., Romualdi C., Beltrame L., Malapelle U., Troncone G., De S., tefano A., Pepe S., De P., lacido S., D'Incalci M., Marchini S., Carlomagno C. Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients. Biomed. Res. Int. 2014, 2014:840921.
21. Uozaki H., Morita S., Kumagai A., Aso T., Soejima Y., Takahashi Y., Fukusato T. Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. Histopathology 2014, (July (8)).
22. Kadera B.E., Li L., Toste P.A., Wu N., Adams C., Dawson D.W., Donahue T.R. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 2013, 8(8):e71978.
23. Sung S.Y., Liao C.H., Wu H.P., Hsiao W.C., Wu I.H., Jinpu Yu., Lin Yu., Lin S.H., Hsieh C.L. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer. PLoS One 2013, 8(8):e71637.
24. Verghese E.T., Drury R., Green C.A., Holliday D.L., Lu X., Nash C., Speirs V., Thorne J.L., Thygesen H.H., Zougman A., Hull M.A., Hanby A.M., Hughes T.A. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion. J. Pathol. 2013, 231(3):388-399.
25. Soon P., Kiaris H. MicroRNAs in the tumour microenvironment: big role for small players. Endocr. Relat. Cancer 2013, 20(5):R257-R267.
26. Cojoc M., Peitzsch C., Trautmann F., Polishchuk L., Telegeev G.D., Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Onco Targets Ther. 2013, 6:1347-1361.
27. Koizumi K., Hojo S., Akashi T., Yasumoto K., Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 2007, 98(11):1652-1658.
28. Orimo A., Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006, 5(15):1597-1601.